Ljungqvist, Ingrid Charlotta (Lotta) (General Electric 201709 CEO of GE Nordics) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United States (USA) |
Lukatch, Heath (Red Tree Venture Capital 202403 formerly Novo A/S 200701) |
n. a. |
Red Tree Venture Capital (US) |
United States (USA) |
Lundberg, Jan M. (Lilly 201003– EVP Science + Technology before AstraZeneca EVP Global Discovery Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
Lundström, Anders (Orexo 201102– CEO before Biogen Idec + AstraZeneca + Janssen-Cilag + BMS) |
Chief Executive Officer (CEO) |
Banner Life Sciences LLC |
United States (USA) |
MacKinnon, Lachlan (Replay 202208 CEO + Co-Founder before Oxford Science Enterprises) |
Chief Executive Officer (CEO) |
Replay (Group) |
United States (USA) |
Maguire, M. Scott (Lipoxen 200612 CEO) |
Chief Executive Officer (CEO) |
Xenetic Biosciences Inc. |
United States (USA) |
Malcolm, Alastair (Applied Microarrays 200705 founder before GE Healthcare before Amersham before Motorola) |
Company Founder |
Schott (Group) |
United States (USA) |
Marks, Ian (Salesforce 202108 VP Life Sciences before GSK + Novartis) |
President/Director/Head Business Group/Unit/Division |
Salesforce.com Inc. (NYSE: CRM) |
United States (USA) |
McComb, Joel (Illumina 200803– SVP + General Manager Life Sciences Business Unit before GE Healthcare before Innovadyne) |
General Manager (management) |
Illumina (Group) |
United States (USA) |
McDonnell, Padraig (Agilent 202405– CEO before SVP + President CrossLab Group before EVP + GM LifeSAM EMEAI) |
Chief Executive Officer (CEO) |
Agilent (Group) |
United States (USA) |
Mohan, Raju (Ventyx Biosciences 202103 CEO + Founder before Escalier Biosciences + Akarna Therapeutics) |
Chief Executive Officer (CEO) |
Ventyx Biosciences Inc. |
United States (USA) |
Narla, Goutham (Univ Michigan 202010 Professor + Rappta Therapeutics 202010 CSO + Co-Founder) |
Professor |
University of Michigan (U-M) |
United States (USA) |
Nell, Peter (Mammoth Biosciences 202001c– CBO before Co-Founder of Casebia) |
Chief Business Officer (CBO) |
Mammoth Biosciences Inc. |
United States (USA) |
Nessi, Claudio (Omega Funds 202211 before NeoMed Management 201309) |
Investment Manager |
Omega Funds (Group) |
United States (USA) |
Nielsen, Jack B. (Novo Capital 202101 formerly 201411 Partner at Novo Ventures) |
Partner (venture partner) |
Vivo Capital (US/CN) |
United States (USA) |
Näveke, Arne (Consilium 202303– Senior Strategic Advisor + head of US before Freeline Therapeutics + Alexion + GSK) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United States (USA) |
Pappas, Arthur (AM Pappas 1994– Managing Parntner + Founder before GSK) |
Managing Partner (investment firm) |
A. M. Pappas & Associates (Pappas Capital / Pappas Ventures) |
United States (USA) |
Patrick, Denis (Pfizer 202007 Managing Partner at Pfizer Ventures) |
Managing Partner (investment firm) |
Pfizer (Group) |
United States (USA) |
Payne, Lloyd (ArrePath 202110– CEO before Evotec + Euprotec) |
Chief Executive Officer (CEO) |
ArrePath (US) |
United States (USA) |
Pegg, Neil (Morningside 202103 at Morningside Ventures) |
Investment Manager |
Morningside (Chan family of Hong Kong) (Group) |
United States (USA) |
Petersen, Deanna M. (AvroBio 202012 CBO) |
Chief Business Officer (CBO) |
AvroBio (Group) |
United States (USA) |
Pettigrew, Michael S. (ESA BioSciences 200804– before GE Healhcare) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
Potter, Matthew B. (Pressure Biosciences 200803– VP Sales before Pharmacia) |
Sales Manager / Marketing Manager |
Pressure BioSciences Inc. (OTCQB: PBIO) |
United States (USA) |
Pullen, Marcus (Cetero Research 201011– Senior Director BusDev Europe before Icon Development Solutions BusDev) |
Business Development Manager / Strategy Manager |
Cetero Research (Group) |
United States (USA) |
Rainin, Ken (Rainin + 1970 co-founder of Anachem) |
Company Founder |
Mettler-Toledo (Mettler Toledo) (Group) |
United States (USA) |
Ravenhill, Neil (Interpublic Group 201401– Director Scienctific Communications Weber Shandwick London before Parexel) |
Public Relations Manager / Investor Relations Manager |
Interpublic Group (IPG) (Group) |
United States (USA) |
Richardson, Reg (ChemBridge 201205 Sales + Business Development Europe) |
Sales Manager / Marketing Manager |
ChemBridge (Group) |
United States (USA) |
Richter, Christine (IO Biotech 202306– SVP Commercial + Program Lead before LEO Pharma + Takeda Oncology + Amgen) |
Chief Commercial Officer (CCO) |
IO Biotech (Group) |
United States (USA) |
Ritschkoff, Anne-Christine (VTT 201110 EVP + Chair VTT/MSI Molecular Sciences Institute Board) |
Chief Executive Officer (CEO) |
VTT Technical Research Centre of Finland Ltd. |
United States (USA) |
Roberts, Charles Campbell (ARK Investment Mananagement 202403 Chief Investment Strategist) |
Investment Manager |
ARK Investment Management LLC |
United States (USA) |
Roberts, Will (G1 Therapeutics 202211 VP IR + Corp Communications before Adaptimmune 201602 VP IR) |
Public Relations Manager / Investor Relations Manager |
G1 Therapeutics Inc. (Nasdaq: GTHX) |
United States (USA) |
Ruotolo, Brandon (Univ Michigan 201804 Prof Analytical Chemistry + ChemBio joined 2009 before Univ Cambridge) |
Professor |
University of Michigan (U-M) |
United States (USA) |
Salinas, Eliseo Oreste (Adolor 200806 CMO before Shire before Wyeth) |
Chief Medical Officer (CMO) |
Adolor Corporation (Nasdaq: ADLR) |
United States (USA) |
Sanchez Sarmiento, Rebeca (Insightful Science 202111– CFO of Insightful Science + Dotmatics before InvestCloud + ATTOM) |
Chief Financial Officer (CFO) |
Insightful Science (Group) |
United States (USA) |
Scott, Nicola (Thermo Fisher 201607) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
Sendek, Joel (Spero Therapeutics 201705– CFO before Forward Pharma A/S + Stifel Financial Corp + Lazard +Progenics) |
Chief Financial Officer (CFO) |
Spero Therapeutics Inc. (Nasdaq: SPRO) |
United States (USA) |
Seymour, Clive (Bruker Daltonics 200812 Executive VP before probably Biacore) |
Regional manager |
Bruker (Group) |
United States (USA) |
Singh, Prahlad (PerkinElmer 201901– COO joined 2014 as President Diagnostics before GE Healthcare + Philips Healthcare) |
Chief Operating Officer (COO) |
PerkinElmer (Group) |
United States (USA) |
Skaletsky, Mark (Trine Pharmaceuticals 200511 CEO + Domantis non-executive Board Chairman) |
Chief Executive Officer (CEO) |
Trine Pharmaceuticals Inc. |
United States (USA) |
Small, Philip William (AMRI 200806– Managing Director Europe before Tripos) |
Managing Director |
Curia (Group) |
United States (USA) |
Stapleton, Michael (Mike) (PerkinElmer 2008– General Manager Informatics before BioWisdom + Invitrogen + Accelrys) |
Chief Business Officer (CBO) |
PerkinElmer (Group) |
United States (USA) |
Sundaram, Senthil (Terns Pharmaceuticals 202101 CEO before NightstaRx + Intercept + Lehman Brothers/Barclays) |
Chief Executive Officer (CEO) |
Terns Pharmaceuticals, Inc. |
United States (USA) |
Vaughan, Tris (AstraZeneca 201808 VP RnD Antibody Discovery + Protein Engineering at MedImmuune) |
Research & Development Manager |
AstraZeneca (Group) |
United States (USA) |
Vidian, Armen (DCVC 2020 Partner) |
Partner (venture partner) |
DCVC (Data Collective) (Group) |
United States (USA) |
Volck, Birgitte (AvroBio 201901– President RnD before GSK + Swedish Orphan Biovitrum) |
Research & Development Manager |
AvroBio (Group) |
United States (USA) |
Wilson, Ian (ImaginAb 201902– CEO joined 201802 as COO before Edinburgh Molecular Imaging + Xstrahl Ltd) |
Chief Executive Officer (CEO) |
ImaginAb Inc. |
United States (USA) |
Witty, Andrew (Hatteras Venture Partners 201709– Venture Partner former GSK CEO 2008–2017 joined 1985) |
Partner (venture partner) |
Hatteras Venture Partners (HVP) |
United States (USA) |
Zheng, Ran (Landmark Bio 202107– CEO before Orchard Therapeutics + Amgen + Diosynth + Genzyme) |
Chief Technology/Technical Officer (CTO) |
Landmark Bio PBLLC |
United States (USA) |